Atreca Inc Stock Current Valuation
Valuation analysis of Atreca Inc helps investors to measure Atreca's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Atreca Inc Company Current Valuation Analysis
Atreca's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Atreca Current Valuation | (17.08 M) |
Most of Atreca's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atreca Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Atreca Inc has a Current Valuation of (17.08 Million). This is 100.12% lower than that of the Biotechnology sector and 100.37% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.1% higher than that of the company.
Atreca Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atreca's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Atreca could also be used in its relative valuation, which is a method of valuing Atreca by comparing valuation metrics of similar companies.Atreca is currently under evaluation in current valuation category among its peers.
Atreca Fundamentals
| Return On Equity | -1.83 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (17.08 M) | |||
| Shares Outstanding | 38.41 M | |||
| Shares Owned By Insiders | 2.73 % | |||
| Shares Owned By Institutions | 24.54 % | |||
| Number Of Shares Shorted | 272.73 K | |||
| Price To Earning | (3.53) X | |||
| Price To Book | 0.28 X | |||
| EBITDA | (76.42 M) | |||
| Net Income | (97.76 M) | |||
| Cash And Equivalents | 101.73 M | |||
| Cash Per Share | 2.64 X | |||
| Total Debt | 63.88 M | |||
| Debt To Equity | 0.57 % | |||
| Current Ratio | 8.14 X | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | (65.08 M) | |||
| Short Ratio | 0.16 X | |||
| Earnings Per Share | (2.50) X | |||
| Target Price | 5.5 | |||
| Number Of Employees | 90 | |||
| Beta | 1.17 | |||
| Market Capitalization | 3.02 M | |||
| Total Asset | 155.03 M | |||
| Retained Earnings | (456.92 M) | |||
| Working Capital | 61.73 M | |||
| Current Asset | 60.02 M | |||
| Current Liabilities | 3.56 M | |||
| Z Score | -5.25 | |||
| Net Asset | 155.03 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |